A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency
Status:
Recruiting
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
VICARES is a prospective randomized, controlled, multi-center, double blind study treating
venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium
Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.